No Data
No Data
Henan Lingrui Pharmaceutical Co., Ltd.'s (SHSE:600285) Stock Is Going Strong: Is the Market Following Fundamentals?
Henan Lingrui Pharmaceutical's (SHSE:600285) stock is up by a considerable 27% over the past three months. Since the market usually pay for a company's long-term fundamentals, we decided to study th
Ling Rui Pharmaceutical (600285.SH): After implementing the holdings reduction, Xinrui Investment reduced its holdings by 1.92% of the company's shares
Gelonghui, May 14, 丨 Ling Rui Pharmaceutical (600285.SH) announced that recently, the company received a “Notice of Shareholding Reduction Results” from Xinrui Investment. As of May 14, 2024, Xinrui Investment had reduced its holdings of the company's shares by 10.867 million shares through bulk transactions, accounting for 1.92% of the company's total share capital before the implementation of the holdings reduction plan. The implementation of this holdings reduction plan was completed.
Lingrui Pharma Gets Green Light to Market Type 2 Diabetes Drug
Chinese drug regulator National Medical Products Administration granted a drug registration certificate to Henan Lingrui Pharmaceutical (SHA:600285) for its metformin hydrochloride extended-release ta
Ling Rui Pharmaceutical (600285.SH): Metformin hydrochloride extended-release tablets obtained drug registration certificate
Gelonghui, May 10, 丨 Ling Rui Pharmaceutical (600285.SH) announced that the company recently received the “Drug Registration Certificate” for metformin hydrochloride extended-release tablets approved and issued by the State Drug Administration. Metformin hydrochloride sustained-release tablets are biguanide hypoglycemic agents, which can reduce the amount of glucose produced by the liver and absorption of glucose by the intestines, and increase insulin sensitivity and lower basal and post-meal blood sugar by increasing the intake and utilization of peripheral glucose.
Henan Lingrui Pharmaceutical Co., Ltd.'s (SHSE:600285) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
Henan Lingrui Pharmaceutical Co., Ltd. (SHSE:600285) shares have continued their recent momentum with a 27% gain in the last month alone. Looking back a bit further, it's encouraging to see the sto
Ling Rui Pharmaceutical (600285.SH): Xinrui Investment plans to reduce its holdings by no more than 1.92%
Gelonghui, May 7 | Ling Rui Pharmaceutical (600285.SH) announced that Xinrui Investment plans to reduce its holdings of the company's shares by no more than 1.92% of the company's total shares through centralized bidding and bulk trading through the Shanghai Stock Exchange trading system.
No Data